European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III

NCT04504006 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

PROCEDURE: Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL)

Sponsor

Dr. Paul Buderath